The Supreme Court building
Pharma

In a big win for generics drugmakers, SCOTUS sides with Hikma

The U.S. Supreme Court has sided with Hikma, ruling that its generic version of Amarin’s Vascepa does not infringe patents held by the Irish company.
Kevin Dunleavy Jun 4, 2026 3:11pm
Zynlonta

Patient deaths raise questions about ADC's cancer drug Zynlonta

Jun 4, 2026 11:38am
Capitol building in Washington
Favicon Fierce Biotech

A divisive bill seeks to limit biotech investment in China

Jun 4, 2026 10:54am
settlement

Axsome bars generic rivals to narcolepsy med Sunosi until 2040

Jun 4, 2026 9:35am
Berlin Germany Brandenburg Gate

Lilly, Boehringer slash investment plans in Germany

Jun 3, 2026 3:10pm
Food and Drug Administration

Regulatory tracker: AbbVie, Amgen score separate EU approvals

Jun 3, 2026 2:50pm
More News

Beaches, birds and more—a tour of ASCO’s exhibit hall floor

Jun 3, 2026 1:28pm

Zevra CEO drafts big ambitions for Miplyffa's US adoption curve

Jun 3, 2026 11:17am

Gilead expanding access to Yescarta, Tecartus with Cencora deal

Jun 3, 2026 11:11am

At ASCO, China biotech industry cements its coming of age

Jun 3, 2026 8:50am